NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Anthony S. Marucci, Interim President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the UBS 2008 Global Life Sciences Conference at the Grand Hyatt New York on Tuesday, September 23, at 2:30 pm, EDT.
